Introduction
Controversy still rages over the comparative nephrotoxicity of aspirin and phenacetin (Kincaid-Smith, 1970; Koutsaimanis and de Wardener, 1970; Prescott, 1970) . Nevertheless, as phenacetin was widely blamed, several of the major proprietary analgesic manufacturers in Britain removed phenacetin from their products in mid-1966. This paper reports on the effect this has had on analgesic nephropathy in Western Scotland.
Patients and Methods
For the purposes of this study analgesic nephropathy was diagnosed only when the following criteria were met. (1) The ingestion of at least 1 g of analgesic daily for three years and the total consumption of a minimum of 3 kg of aspirin or phenacetin. (2) The exclusion of any other cause of renal disease. (3)
Creatinine clearance of 75 ml/minute or less.
Between 1965 and 1971 83 such patients presented to the renal unit of the Western Infirmary, Glasgow (Murray et al., 1971a (Murray et al., , 1971b Murray, 1972; Murray and Smith, 1972 Patients with Established Analgesic Nephropathy.-As it has been shown that recovery ofrenal function depends on abstinence from analgesics (Bell et al., 1969; Kincaid-Smith, 1970; Nitzsche and Bock, 1970; Murray et al., 1971a) , patients were repeatedly advised to stop taking them. In spite of this 31 patients continued their analgesic abuse unabated. These were divided into those who continued to take preparations containing phenacetin (17 cases) and those who took preparations (Askit Powders and Beecham's Powders) from which the phenacetin had been removed (12 cases). Two patients continued abusing both types. Of the 17 patients taking preparations contining phenacetin renal function deteriorated in 14 of whom nine died of uraemia. Renal function declined in nine out of the 12 taking preparations which did not contain phenacetin and three of these died of renal failure (Fig. 2) rapid in the former group, who showed a mean yearly decrease in creatinine clearance of 12x9 ml/min compared with 4 9 ml/min in those taking preparations not containing phenacetin.
Discussion
The major ingredients of analgesic mixtures-aspirin, phenacetin, and phenazone-have all been shown to be nephrotoxic, and not even caffeine has a clear record (Prescott, 1970) . Although most cases of analgesic nephropathy have followed the abuse of compound analgesics, most clinicians have blamed the phenacetin for this (Shelley, 1967; Abel, 1971) . Analgesic nephropathy, however, has never been recorded after phenacetin alone, and recent work suggests that aspirin is the major cause of experimentally-induced papillary necrosis (Nanra and Kincaid-Smith, 1970) . It is therefore of both theoretical and practical interest to establish what effect the withdrawal of phenacetin from proprietary analgesics has had. The fall in the number of cases presenting to us in 1971 is interesting but clearly too much should not be made of the figures for one year. The relative decline in importance of Askit Powders and Beecham's Powders is more significant, and suggests that the removal of phenacetin from these preparations has been beneficial. Certainly a decrease in analgesic nephropathy was reported from Scandinavia where phenacetin was restricted to prescription in 1961 and consumption fell tenfold. In Sweden Bengtsson (1967) noted a steady fall in the percentage of cases of "chronic pyelonephritis" related to analgesic ingestion from 58% in 1961 to 25% in 1965 , and stated (Bengtsson, 1969 ) that the "pattern of chronic non-obstructive pyelonephritis is changing in a favourable direction." Similarly, Nordonfeldt (1972) found a decrease in the number of deaths from analgesic nephropathy from 1967 onwards, while in Denmark Kjaerulff and Harvald (1968) found that the incidence of renal papillary necrosis declined from 4% of all necropsies in 1959 to 2% in 1967. On the other hand, in Australia substitution of paracetamol for phenacetin in aspirin-phenacetin-caffeine mixtures is said to have made little difference to the incidence of new cases (Kincaid-Smith, 1970) .
The critical therapeutic measure for patients with established analgesic nephropathy is to withdraw the compound analgesic, but so intense is their dependence on analgesics that they often continue to consume these drugs against medical advice (Murray, 1972) . The evidence of the present study is that abuse of aspirin and caffeine mixtures does lead to further renal damage, but is not so dangerous as abuse of preparations also containing phenacetin. This would explain why some patients are still presenting with uraemia from abuse of Askit Powders and Beecham's Powders. Presumably the bulk of the renal damage was done before 1966 but slow deterioration has continued since then.
These findings do not incriminate phenacetin as the sole cause of the nephrotoxicity of compound analgesics. Phenacetin may merely potentiate the nephrotoxicity of other analgesics.
It appears, however, that the removal of phenacetin from some proprietary analgesics is having a beneficial effect on analgesic nephropathy in Western Scotland and that further practical improvement would follow its removal from the B.P. preparation compound codeine tablets. 
